Home » Stocks » Generation Bio

Generation Bio Co. (GBIO)

Stock Price: $30.11 USD 2.73 (9.97%)
Updated Sep 25, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.40B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 46.43M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 25, 2020
Last Price $30.11
Previous Close $27.38
Change ($) 2.73
Change (%) 9.97%
Day's Open 27.31
Day's Range 27.31 - 30.40
Day's Volume 222,012
52-Week Range 17.00 - 32.18

More Stats

Market Cap 1.40B
Enterprise Value 1.10B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.43M
Float 29.63M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 646,964
Short Ratio 5.01
Short % of Float 1.79%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.18
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 301.09M
Net Cash / Share 6.49
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(8.50% upside)
Current: $30.11
Target: 32.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit-0.04
Operating Income-62.30-37.29
Net Income-61.32-35.80
Shares Outstanding4.733.35
Earnings Per Share-12.96-10.69
Operating Cash Flow-40.35-28.12
Capital Expenditures-19.91-3.02
Free Cash Flow-60.25-31.14
Cash & Equivalents15.1374.92
Net Cash / Debt15.1374.92
Book Value-98.59-41.59
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Generation Bio Co.
Country United States
CEO Cameron Geoffrey McDonough

Stock Information

Ticker Symbol GBIO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: GBIO
IPO Date June 12, 2020


Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.